SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-15-007418
Filing Date
2015-10-01
Accepted
2015-10-01 17:03:09
Documents
6
Period of Report
2015-10-01

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k100115_biondvax.htm 6-K 15713
2 PRESS RELEASE, DATED SEPTEMBER 30, 2015 f6k100115ex99i_biondvax.htm EX-99.1 15668
3 PRESS RELEASE, DATED OCTOBER 1, 2015 f6k100115ex99ii_biondvax.htm EX-99.2 16866
4 GRAPHIC image_002.gif GRAPHIC 170
5 GRAPHIC image_002.jpg GRAPHIC 4559
6 GRAPHIC image_003.gif GRAPHIC 187
  Complete submission text file 0001213900-15-007418.txt   56433
Mailing Address 14 EINSTEIN ST. NES-ZIONA L3 74036
Business Address 14 EINSTEIN ST. NES-ZIONA L3 74036 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1213
Type: 6-K | Act: 34 | File No.: 001-37353 | Film No.: 151137690
SIC: 2836 Biological Products, (No Diagnostic Substances)